BridgeMD
New treatment option for Soft Tissue Sarcoma Adult
Official title Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas
ClinicalTrials.gov ID: NCT06385288
What this study is testing
- What it's testing
- "Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcoma" is a prospective study with additional translational research using preoperative and postoperative tissue, blood sampling and advanced imaging.
- Time commitment: about 5 years
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Planned histological confirmation for especially high-risk soft tissue sarcoma via open Sampling
- Indication for neoadjuvant multimodal therapy (radiation and locoregional Hyperthermia, optionally with simultaneous chemotherapy)
- Planned resection of a department of the CWS
- Age \> 18 years
- Ability to consent
You likely can't join if
- Age \< 18 years
- Poor understanding (language etc.)
- Lack of reconnaissance ability
See the full eligibility criteria
- Planned histological confirmation for especially high-risk soft tissue sarcoma via open Sampling
- Indication for neoadjuvant multimodal therapy (radiation and locoregional Hyperthermia, optionally with simultaneous chemotherapy)
- Planned resection of a department of the CWS
- Age \> 18 years
- Ability to consent
- Additionally for imaging study: Treatment on the combined MR hyperthermia device
- Age \< 18 years
- Poor understanding (language etc.)
- Lack of reconnaissance ability
The study team makes the final eligibility decision.
Where it's taking place
- Tübingen, Baden-Wurttemberg, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 5 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tübingen, Baden-Wurttemberg, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.